Sebastian Meyer

Title: The Innovative Contributions of Sebastian Meyer

Introduction

Sebastian Meyer is a prominent inventor based in Eggenwil, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 17 patents to his name, Meyer has established himself as a key figure in the innovation landscape.

Latest Patents

Meyer’s latest patents include groundbreaking inventions such as "Anti-TNF-alpha-antibodies and functional fragments thereof." This invention relates to antibody molecules capable of binding to tumor necrosis factor alpha (TNFα), along with processes for their production and therapeutic uses. Another notable patent is the "Multispecific antibody comprising CD137 binding domain and PDL1 binding domain." This invention encompasses a multispecific antibody that includes at least one CD137 binding domain and at least one PDL1 binding domain, along with pharmaceutical compositions and methods of use.

Career Highlights

Throughout his career, Sebastian Meyer has worked with notable companies in the biotechnology sector, including Numab Therapeutics AG and Numab Innovation AG. His work in these organizations has contributed to advancements in therapeutic solutions and innovative drug development.

Collaborations

Meyer has collaborated with several professionals in his field, including Tea Gunde and David M. Urech. These collaborations have further enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Sebastian Meyer’s contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic treatments and antibody development.